No Data
No Data
No Data
No Data
No Data
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAcrivon Therapeutics (NASDAQ:ACRV) stock rose 12.3% to $10.67 during Wednesday's after-market session. The market value of their outstanding shares is at $329.4 million. Amarin Corp (NASDAQ:AMR
BenzingaApr 25 04:31
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersImmutep (NASDAQ:IMMP) stock increased by 15.5% to $2.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $344.7 million. Syra Health (NASDAQ:SYRA) stock
BenzingaApr 24 20:06
BiomX to Present Data From Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients With Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
Abstract selected as a "Top Poster", ranking it among the 1-2% of top-rated abstracts in the category submitted and accepted at ECCMID 2024CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 23, 2024 (GL
GlobeNewswireApr 23 20:00
HC Wainwright & Co. : The BioMX (PHGE.US) rating was confirmed and adjusted from buy to buy, with a target price of $2.00.
HC Wainwright & Co. : The BioMX (PHGE.US) rating was confirmed and adjusted from buy to buy, with a target price of $2.00.
Zhitong FinanceApr 22 18:40
BiomX's BX211 Phage Therapy: A Revolutionary Approach to Diabetic Foot Osteomyelitis Treatment
TipRanksApr 22 18:16
Press Release: BiomX Announces the Appointment of Susan Blum to Its Board of Directors
BiomX Announces the Appointment of Susan Blum to its Board of Directors CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) ("BiomX" or the "C
Dow JonesApr 18 20:00
No Data
No Data